NPs Basic Information
|
Name |
Pestalotiollide B
|
| Molecular Formula | C21H22O7 | |
| IUPAC Name* |
2-[(1S,2S)-1,2-dihydroxy-3-methylbut-3-enyl]-6-hydroxy-1-methoxy-8-methyl-10H-benzo[b][1,5]benzodioxocin-12-one
|
|
| SMILES |
CC1=CC2=C(C(=C1)O)OC3=C(C(=C(C=C3)[C@@H]([C@H](C(=C)C)O)O)OC)C(=O)OC2
|
|
| InChI |
InChI=1S/C21H22O7/c1-10(2)17(23)18(24)13-5-6-15-16(20(13)26-4)21(25)27-9-12-7-11(3)8-14(22)19(12)28-15/h5-8,17-18,22-24H,1,9H2,2-4H3/t17-,18-/m0/s1
|
|
| InChIKey |
HHLSDNCZICXJDV-ROUUACIJSA-N
|
|
| Synonyms |
Pestalotiollide B
|
|
| CAS | NA | |
| PubChem CID | 52920650 | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 386.4 | ALogp: | 2.6 |
| HBD: | 3 | HBA: | 7 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 105.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 28 | QED Weighted: | 0.54 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.964 | MDCK Permeability: | 0.00001630 |
| Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0.024 |
| Human Intestinal Absorption (HIA): | 0.038 | 20% Bioavailability (F20%): | 0.015 |
| 30% Bioavailability (F30%): | 0.003 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.157 | Plasma Protein Binding (PPB): | 92.57% |
| Volume Distribution (VD): | 0.995 | Fu: | 8.30% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.71 | CYP1A2-substrate: | 0.788 |
| CYP2C19-inhibitor: | 0.215 | CYP2C19-substrate: | 0.453 |
| CYP2C9-inhibitor: | 0.175 | CYP2C9-substrate: | 0.555 |
| CYP2D6-inhibitor: | 0.478 | CYP2D6-substrate: | 0.277 |
| CYP3A4-inhibitor: | 0.155 | CYP3A4-substrate: | 0.334 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 13.104 | Half-life (T1/2): | 0.488 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.034 | Human Hepatotoxicity (H-HT): | 0.014 |
| Drug-inuced Liver Injury (DILI): | 0.278 | AMES Toxicity: | 0.321 |
| Rat Oral Acute Toxicity: | 0.867 | Maximum Recommended Daily Dose: | 0.909 |
| Skin Sensitization: | 0.225 | Carcinogencity: | 0.784 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.166 |
| Respiratory Toxicity: | 0.364 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC006148 |  |
1.000 | D0F7CS |  |
0.295 | ||
| ENC002739 |  |
1.000 | D07MGA |  |
0.292 | ||
| ENC004016 |  |
0.786 | D0L1JW |  |
0.289 | ||
| ENC004017 |  |
0.744 | D04UTT |  |
0.283 | ||
| ENC000877 |  |
0.724 | D06GCK |  |
0.283 | ||
| ENC001921 |  |
0.724 | D04TDQ |  |
0.268 | ||
| ENC004018 |  |
0.705 | D09DHY |  |
0.258 | ||
| ENC002005 |  |
0.663 | D0G4KG |  |
0.252 | ||
| ENC006147 |  |
0.613 | D0W8WB |  |
0.252 | ||
| ENC001927 |  |
0.577 | D06GIP |  |
0.250 | ||